Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Anders Elm, Pedersen"'
Autor:
Mohammad Yassin, Hannelouise Kissow, Ben Vainer, Philomeena Daphne Joseph, Anders Hay-Schmidt, Jørgen Olsen, Anders Elm Pedersen
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-16 (2018)
Abstract Cytoglobin (Cygb) is a member of the hemoglobin family and is thought to protect against cellular hypoxia and oxidative stress. These functions may be particularly important in inflammation-induced cancer, e.g., in patients with ulcerative c
Externí odkaz:
https://doaj.org/article/c4b5c3bc858a41238a99f434fd263849
Autor:
Dina Leth Møller, Katrine Kielsen, Claus Henrik Nielsen, Henrik Sengeløv, Anders Elm Pedersen, Lars Peter Ryder, Klaus Müller
Publikováno v:
Immunopharmacology and Immunotoxicology. 44:1004-1012
Thymic stromal lymphopoietin (TSLP) is an immunoregulatory, Th2-polarizing cytokine produced by epithelial cells. We hypothesized that TSLP affects immune reconstitution after hematopoietic stem cell transplantation (HSCT) leading to increased allore
Autor:
Katrine Kielsen, Christian Enevold, Carsten Heilmann, Henrik Sengeløv, Anders Elm Pedersen, Lars P. Ryder, Klaus Müller
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by acute and chronic graft-versus-host disease (aGVHD and cGVHD) and viral infections due to long-lasting immunodeficiency. Interleukin-7 (IL-7) is a cytokine ess
Externí odkaz:
https://doaj.org/article/85f0b188fc5241f784542ca1ecdaac3a
Autor:
Mikkel Møller Andersen, Jesper Larsen, Anders Elm Pedersen, Monika Gad, Morten Hartvig Hansen
Publikováno v:
Immunological Investigations. 50:527-543
Cancer immunotherapies have achieved much success and have become the forefront treatment of cancers previously associated with poor prognosis. However, a major challenge in cancer immunotherapies ...
Autor:
Peter Tougaard, Camilla Hartmann Friis Hansen, Peter Vandenabeele, Mette Flethøj, Axel Kornerup Hansen, Søren Skov, Louise Otterstrøm Martinsen, Anders Elm Pedersen, Ditte Olsen Lützhøft, Henrik Jeldtoft Jensen
Publikováno v:
International Journal of Obesity. 44:1062-1074
TL1A is a pro-inflammatory cytokine that is homologous to TNFα and connected with the development of several chronic inflammatory disorders. The preliminary results of this study indicated reduced fat accumulation in 9-month-old TL1A-deficient mice
Autor:
Kåre Håkansson, Claus Bachert, Lars Konge, Simon Francis Thomsen, Anders Elm Pedersen, Steen Seier Poulsen, Tomas Martin-Bertelsen, Ole Winther, Vibeke Backer, Christian von Buchwald
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0127228 (2015)
It has been established that patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often have co-existing asthma.We aimed to test two hypotheses: (i) upper and lower airway inflammation in CRSwNP is uniform in agreement with the united airw
Externí odkaz:
https://doaj.org/article/b8114b3be07846678fd6bed6315d19ac
Autor:
Manja Idorn, Adnan Halim, Henrik Ipsen, Svenning Rune Møller, Per thor Straten, Peter Adler Würtzen, Michael C. Carlsson, Sally Dabelsteen, Caroline Benedicte Kjærulff Mathiesen, Hans H. Wandall, Stephanie Brand, Bent O. Petersen, Jens Brimnes, Anders Elm Pedersen
Publikováno v:
Journal of Allergy and Clinical Immunology. 142:1983-1987
Autor:
Caroline B Madsen, Kirstine Lavrsen, Catharina Steentoft, Malene B Vester-Christensen, Henrik Clausen, Hans H Wandall, Anders Elm Pedersen
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72413 (2013)
Membrane bound mucins are up-regulated and aberrantly glycosylated during malignant transformation in many cancer cells. This results in a negatively charged glycoprotein coat which may protect cancer cells from immune surveillance. However, only lim
Externí odkaz:
https://doaj.org/article/d29f6a412dca4efc8e46d49fbb687bc5
Autor:
Caroline B. Madsen, Kirstine Lavrsen, Catharina Steentoft, Malene B. Vester-Christensen, Henrik Clausen, Hans H. Wandall, Anders Elm Pedersen
Publikováno v:
PLoS ONE, Vol 8, Iss 10 (2013)
Externí odkaz:
https://doaj.org/article/47ce4dcd4e4e4db1ac47ba1bb9e43a57
Publikováno v:
Immunological investigations. 50(5)
Cancer immunotherapies have achieved much success and have become the forefront treatment of cancers previously associated with poor prognosis. However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory cap